Clinical Trials Browser

Completed × Colorectal Neoplasms × obinutuzumab × Clear all

NCT04826003 2025-07-14

Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment

Phase 1 Completed

Gastrointestinal

Colorectal Neoplasms